DR. STEFANIE CROMHEECKE

Active

Private limited company (pre-2019)founded 2007active for 19 yearsListdreef 6, 2900 Schoten, BelgiumKBO/BCE: BE 0891.444.648

From the official registers: KBO 19 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. STEFANIE CROMHEECKE has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €896,466 and a net result of €134,134. Equity remains stable across the filed financial years (±1% per year). Its solvency ranks better than 40% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

DR. STEFANIE CROMHEECKEActiveChecked score 91/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 16-08-2007 Normal situation
Legal form: Private limited company (pre-2019)
Registered office: Listdreef 6, 2900 Schoten
Activity: Specialist medical practice NACE 86220and 1 other
Establishment unit: 2.301.941.939 2900 Schoten, since 16-08-2007
Financial year end: 31 December
Peppol: Reachable since 31-03-2026

Company details

Who decides

Board

Cromheecke StefanieDirector · since 09-08-2007

Board & ownership

How it is doing

91 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts 2025

Gross margin: €260,844; ▼ 40.5%
Turnover: ≈ €400,000; estimated
Profit: €134,134; ▼ 23.1%
Equity: €896,466; ▲ 3.3%
Total assets: €1.7m; ▼ 1.8%

2025 accounts 14 days early

Filed on 17-07-2026at the National Bank

Financials

Why 91raises risk1 of the last 3 latelowers riskSector: Human health activities (NACE 86)Size: total assets €1.7mFigures for financial year 2025 (filed 17-07-2026)Show the evidence

Checked score

Score 2025

91 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 26% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Average

Solvency 77+3

equity 51.6% of total assets

Liquidity 33-6

short-term debt 48.4% · cash 5.5%

Profitability 64+11

return on assets 7.7%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.2%▲ +0.1 percentage points vs 09-2025highest value 11-2025: < 0.1%▼ -0.2 percentage points vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: 0.1%▲ +0.1 percentage points vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €80,000 on 30-day terms is acceptable

Liquidity ample (current ratio 1.91, compared with 1.8 in 2024, above the usual 1.5; short-term debt: 48.4% and cash: 5.5% of total assets), and 48.4% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 41% on solvency, 7% on liquidity, 11% on profitability and 43% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Sector: Human health activities (NACE 86)

KBO

Size: total assets €1.7m

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

1 of the last 3 late

NBB · filings

Figures for financial year 2025 (filed 17-07-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

14 days early

2024

61 days late

2023

30 days late

2022

58 days late

2021

61 days late

2020

31 days late

2019

91 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 45 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 September (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Among the best 8% on equitysector median €124,628 · 20,680 companies €896,466 View
Positive: 8 profitable years in a rowprofit 2025: €134,134 8 years View

Documents

Key facts about DR. STEFANIE CROMHEECKE

What is the company number of DR. STEFANIE CROMHEECKE?: 0891.444.648. In Belgium the VAT number is the company number with BE in front: BE 0891.444.648.
Where is DR. STEFANIE CROMHEECKE based?: The registered office is at Listdreef 6, 2900 Schoten.Company details
What does DR. STEFANIE CROMHEECKE do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. STEFANIE CROMHEECKE?: Private limited company (pre-2019) (BVBA).
When was DR. STEFANIE CROMHEECKE founded?: On 16-08-2007.
Is DR. STEFANIE CROMHEECKE still active?: Yes, DR. STEFANIE CROMHEECKE is an active enterprise in the KBO register.
What is the turnover of DR. STEFANIE CROMHEECKE?: ≈ €400,000 in financial year 2025. Estimated from the gross margin of €260,844: probably between €360,000 and €510,000, based on 36 comparable companies, NACE 862.Financials
Is DR. STEFANIE CROMHEECKE profitable?: In financial year 2025, DR. STEFANIE CROMHEECKE made a profit of €134,134.
Where can I find the annual accounts of DR. STEFANIE CROMHEECKE?: DR. STEFANIE CROMHEECKE filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. STEFANIE CROMHEECKE due?: By 31-07-2027, for financial year 2026.Timeline

Companies related to DR. STEFANIE CROMHEECKE

Comparable companies

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Overview